Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2025-12-24 @ 4:13 PM
NCT ID:
NCT00623766
Brief Summary:
To assess the response of melanoma with brain metastases to ipilimumab treatment while maintaining acceptable tolerability.
Study:
NCT00623766
Study Brief:
Protocol Section:
NCT00623766